Cardiff Oncology, Inc.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
0.62 |
0.43 |
0.33 |
0.10 |
0.20 |
101.51 |
Przychód Δ r/r |
0.00% |
-30.74% |
-23.99% |
-69.58% |
100.00% |
50653.75% |
Przychód (min) |
0.51 |
0.14 |
0.13 |
0.04 |
0.08 |
39.70 |
Przychód (max) |
0.77 |
0.72 |
0.49 |
0.15 |
0.30 |
152.83 |
EBITDA (średnia) |
-0.62 |
-0.43 |
-0.33 |
-0.10 |
-0.20 |
-101.51 |
EBIT (średnia) |
-0.62 |
-0.43 |
-0.33 |
-0.10 |
-0.20 |
-101.51 |
EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
Zysk netto (średni) |
-46.61 |
-39.67 |
-40.74 |
-47.14 |
-79.81 |
-49.18 |
Zysk netto % |
-7463.27% |
-9171.94% |
-12391.75% |
-47136.57% |
-39905.21% |
-48.45% |
EPS (średnia) |
-0.99 |
-0.83 |
-0.86 |
-1.07 |
-1.67 |
-1.03 |
Liczba analityków (Przychody) |
5 |
4 |
8 |
5 |
1 |
2 |
Liczba analityków (EPS) |
4 |
5 |
7 |
5 |
2 |
1 |
symbol |
CRDF |
CRDF |
CRDF |
CRDF |
CRDF |
CRDF |